Advaxis and Sellas Life Sciences Group, two companies that have pursued different ways of prompting the body’s immune system to fight cancer, are now hoping that combining their efforts will lead to a more precise treatment. The agreement between the companies calls for Princeton, NJ-based Advaxis (NASDAQ: ADXS) to license to Sellas its technology for […]
What Our Clients Say
[ssba_hide]
[testimonials category="Testimonial" random=true limit="1"]
Press Releases and Whitepapers
Industry News & Articles
- NASA picks Eric Schmidt’s rocket company for Mars mission, setting up a race with SpaceX
- How to turn off AI in your Google Docs
- AI is hurting Apple in more ways than one: it may force iPhone price increases
- Chi-Hua Chien saw Facebook coming; now he says the real AI winners won’t be selling AI
- Roelof Botha joins SpaceX’s board of directors
- After unveiling ridiculously expensive AR glasses, Snap’s stock takes a dive
- NEA’s Tiffany Luck says enterprises are still figuring out their AI ROI
- FTC lawsuit reveals how subscription scam networks evade app store enforcement
Sample Relationships
[logo-carousel id=relationships]
Notables
[logo-carousel id=notables]